Lv1
50 积分 2025-05-20 加入
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
20小时前
已完结
Myasthenia gravis: Mechanisms, clinical syndromes, and diagnosis
20小时前
已完结
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature
11个月前
已完结
Ulcerative colitis as a progressive disease: the forgotten evidence
1年前
已完结
皖公网安备34019202002308
